Hepatitis B virus associated focal and segmental glomerular sclerosis: report of two cases and review of literature

Clin Exp Nephrol. 2009 Aug;13(4):373-377. doi: 10.1007/s10157-008-0124-8. Epub 2009 Jan 24.

Abstract

The hepatitis B virus (HBV) is estimated to have infected about 350 million people worldwide, making it one of the most common human pathogens. Renal involvement is among its most common extra hepatic manifestations and usually manifests in the form of immune complex mediated glomerulopathy, such as membranous glomerulonephritis (MGN), membranoproliferative glomerulonephritis (MPGN), mesangioproliferative glomerulonephritis and immunoglobulin A (IgA) nephropathy. Occurrence of focal and segmental glomerular sclerosis (FSGS) with HBV infection is rare and only five cases have been reported earlier. We report two cases of hepatitis B associated FSGS. In both the cases, HBsAg was demonstrated in the renal tissue and both the cases showed response to treatment with lamivudine, thus indicating a possible causal association between the viral infection and occurrence of nephrotic syndrome.

Publication types

  • Case Reports
  • Review

MeSH terms

  • Adolescent
  • Biopsy
  • DNA, Viral / blood
  • Glomerulosclerosis, Focal Segmental / drug therapy
  • Glomerulosclerosis, Focal Segmental / virology*
  • Hepatitis B / complications*
  • Hepatitis B / diagnosis
  • Hepatitis B / drug therapy
  • Hepatitis B Antigens / analysis*
  • Hepatitis B Core Antigens / analysis
  • Hepatitis B Surface Antigens / analysis
  • Hepatitis B virus / genetics
  • Hepatitis B virus / immunology*
  • Humans
  • Immunohistochemistry
  • Kidney / virology*
  • Lamivudine / therapeutic use
  • Male
  • Nephrotic Syndrome / drug therapy
  • Nephrotic Syndrome / virology*
  • Proteinuria / virology
  • Treatment Outcome

Substances

  • DNA, Viral
  • Hepatitis B Antigens
  • Hepatitis B Core Antigens
  • Hepatitis B Surface Antigens
  • Lamivudine